Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging

被引:76
|
作者
Saheera, Sherin [1 ]
Krishnamurthy, Prasanna [2 ,3 ]
机构
[1] Univ Massachusetts, Dept Cardiovasc Med, Med Sch, Worcester, MA USA
[2] Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, 1675 Univ Blvd,Volker Hall G094, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Engn, 1675 Univ Blvd,Volker Hall G094, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
hypertension; aging; cardiac hypertrophy; heart failure; LEFT-VENTRICULAR HYPERTROPHY; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; TRANSITION; FAILURE; MICE; RAT; AGE;
D O I
10.1177/0963689720920830
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Cardiovascular diseases are the leading cause of mortality and morbidity worldwide and account for more than 17.9 million deaths (World Health Organization report). Hypertension and aging are two major risk factors for the development of cardiac structural and functional abnormalities. Hypertension, or elevated blood pressure, if left untreated can result in myocardial hypertrophy leading to heart failure (HF). Left ventricular hypertrophy consequent to pressure overload is recognized as the most important predictor of congestive HF and sudden death. The pathological changes occurring during hypertensive heart disease are very complex and involve many cellular and molecular alterations. In contrast, the cardiac changes that occur with aging are a slow but life-long process and involve all of the structural components in the heart and vasculature. However, these structural changes in the cardiovascular system lead to alterations in overall cardiac physiology and function. The pace at which these pathophysiological changes occur varies between individuals owing to many genetic and environmental risk factors. This review highlights the molecular mechanisms of cardiac structural and functional alterations associated with hypertension and aging.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Blockade of the Neprilysin and Angiotensin Ameliorates Oxidative Stress in the Cardiovascular Target Tissues of Dexamethasone-induced Hypertensive Rats
    Aykan, Duygun Altintas
    Seyithanoglu, Muhammed
    Eser, Nadire
    Tanriverdi, Burak
    Yaman, Selma
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2020, 58 (01): : 1 - 8
  • [42] Oxidative Stress & FoxO Transcription Factors in Cardiovascular Aging
    Kim, Juewon
    Cho, Si Y.
    Cho, Donghyun
    Kim, Su H.
    Seo, Dae B.
    Shin, Song S.
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (09) : 943 - 949
  • [43] Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action
    Diez, Javier
    Butler, Javed
    HYPERTENSION, 2023, 80 (01) : 13 - 21
  • [44] Brain and cardiovascular-related changes are associated with aging, hypertension, and atrial fibrillation
    Rim, Donggyu
    Henderson, Luke A.
    Macefield, Vaughan G.
    CLINICAL AUTONOMIC RESEARCH, 2022, 32 (06) : 409 - 422
  • [45] The constellation of hypertensive heart disease
    Pavlopoulos, Harry
    Nihoyannopoulos, Petros
    HELLENIC JOURNAL OF CARDIOLOGY, 2008, 49 (02) : 92 - 99
  • [46] Autophagy in Hypertensive Heart Disease
    Wang, Zhao V.
    Rothermel, Beverly A.
    Hill, Joseph A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (12) : 8509 - 8514
  • [47] A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading
    Tsukamoto, Yasumasa
    Mano, Toshiaki
    Sakata, Yasushi
    Ohtani, Tomohito
    Takeda, Yasuharu
    Tamaki, Shunsuke
    Omori, Yosuke
    Ikeya, Yukitoshi
    Saito, Yuki
    Ishii, Ryohei
    Higashimori, Mitsuru
    Kaneko, Makoto
    Miwa, Takeshi
    Yamamoto, Kazuhiro
    Komuro, Issei
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2013, 305 (11): : H1658 - H1667
  • [48] Neuromodulation Device Therapy for Treatment of Hypertensive Heart Disease
    Todoran, Thomas M.
    Zile, Michael R.
    CIRCULATION JOURNAL, 2013, 77 (06) : 1351 - 1363
  • [49] Hypertensive heart disease: risk factors, complications and mechanisms
    Masenga, Sepiso K.
    Kirabo, Annet
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [50] Sirtuins, aging, and cardiovascular risks
    Favero, Gaia
    Franceschetti, Lorenzo
    Rodella, Luigi Fabrizio
    Rezzani, Rita
    AGE, 2015, 37 (04)